골밀도 보충제 시장 규모, 점유율, 동향 분석 보고서 : 원료별, 제제별, 소비자 그룹별, 판매 채널별, 지역별, 부문별 예측(2025-2033년)

Bone Density Supplements Market Size, Share & Trends Analysis Report By Ingredient (Multi-ingredient, Single-ingredient), By Formulation (Tablets, Capsules), By Consumer Group, By Sales Channel, By Region, And Segment Forecasts, 2025 - 2033

US $ 5,950 ￦ 8,620,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,069,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,967,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

골밀도 보충제 시장 요약

세계의 골밀도 보충제 시장 규모는 2024년에 28억 3,000만 달러로 추정되며, 2033년까지 61억 7,000만 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 CAGR 9.10%로 확대될 것으로 예상됩니다. 골다공증 및 기타 뼈 관련 질환의 발생률 증가, 뼈 건강에 대한 인식의 증가, 전 세계 고령화 인구의 증가가 시장 확대를 이끄는 주요 요인으로 작용하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향 및 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련·부수 시장 전망
• 시장 역학
• 업계 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석

제4장 원료별 비즈니스 분석

• 골밀도 보충제 시장 : 원료별 변동 분석
• 다성분 보충제
• 단일 성분 보충제

제5장 제제별 비즈니스 분석

• 골밀도 보충제 시장 : 제제별 변동 분석
• 정제
• 캡슐
• 분말
• 소프트젤
• 기타

제6장 소비자 그룹별 비즈니스 분석

• 골밀도 보충제 시장 : 소비자 그룹별 변동 분석
• 소아
• 성인
• 임산부
• 노인

제7장 판매 채널별 비즈니스 분석

• 골밀도 보충제 시장 : 판매 채널별 변동 분석
• 실점포
• E-Commerce

제8장 지역별 사업 분석

• 골밀도 보충제 지역별 시장 점유율, 2024년 및 2033년
• 북미
  • 북미의 골밀도 보충제 시장, 2021-2033년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 골밀도 보충제 시장, 2021-2033년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 골밀도 보충제 시장, 2021-2033년
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 라틴아메리카의 골밀도 보충제 시장, 2021-2033년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 골밀도 보충제 시장, 2021-2033년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 기업 분류
• 전략 매핑
• 2024년의 기업 시장 상황 분석
• 기업 개요/리스트
  • New Chapter
  • Nature Made
  • Nature's Bounty
  • Amway
  • Life Extension
  • Thorne
  • Solgar Inc.
  • Pure Encapsulations, LLC.
  • Glanbia plc
  • NOW Foods

KSM

영문 목차

영문목차

Bone Density Supplements Market Summary

The global bone density supplements market size was estimated at USD 2.83 billion in 2024 and is projected to reach USD 6.17 billion by 2033, expanding at a CAGR of 9.10% from 2025 to 2033. The growing incidence of osteoporosis and other bone-related conditions, combined with increasing awareness of bone health and the global aging population, are the primary factors driving market expansion.

Global Bone Density Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bone density supplements market report based on ingredient, formulation, consumer group, sales channel, and region:

• Ingredient Outlook (Revenue, USD Million, 2021 - 2033)
• Multi-ingredient Supplements
• Single-ingredient Supplements
  • Calcium Supplements
  • Magnesium Supplements
  • Vitamin D Supplements
  • Collagen Supplements
  • Others
• Formulation Outlook (Revenue, USD Million, 2021 - 2033)
• Tablets
• Capsules
• Powders
• Softgels
• Others
• Consumer Group Outlook (Revenue, USD Million, 2021 - 2033)
• Children
• Adults
• Pregnant Women
• Geriatric Population
• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Brick And Mortar
  • Direct Selling
  • Chemists/Pharmacies
  • Health Food Shops
  • Hypermarkets
  • Supermarkets
• E-Commerce
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objective
  • 1.4.1. Objective 1
  • 1.4.2. Objective 2
  • 1.4.3. Objective 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis:
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing aging population
    • 3.2.1.2. Rising awareness about preventive health
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory challenges
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Ingredient Business Analysis

• 4.1. Segment Dashboard
• 4.2. Bone Density Supplements Market: Ingredient Movement Analysis
• 4.3. Multi-ingredient Supplements
  • 4.3.1. Multi-ingredient Supplements Market, 2021 - 2033 (USD Million)
• 4.4. Single-ingredient Supplements
  • 4.4.1. Single-ingredient Supplements Market, 2021 - 2033 (USD Million)
    • 4.4.1.1. Calcium Supplements
      • 4.4.1.1.1. Calcium Supplements Market, 2021 - 2033 (USD Million)
    • 4.4.1.2. Magnesium Supplements
      • 4.4.1.2.1. Magnesium Supplements Market, 2021 - 2033 (USD Million)
    • 4.4.1.3. Vitamin D Supplements
      • 4.4.1.3.1. Vitamin D Supplements Market, 2021 - 2033 (USD Million)
    • 4.4.1.4. Collagen Supplements
      • 4.4.1.4.1. Collagen Supplements Market, 2021 - 2033 (USD Million)
    • 4.4.1.5. Others
      • 4.4.1.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Formulation Business Analysis

• 5.1. Segment Dashboard
• 5.2. Bone Density Supplements Market: Formulation Movement Analysis
• 5.3. Tablets
  • 5.3.1. Tablets Market, 2021 - 2033 (USD Million)
• 5.4. Capsules
  • 5.4.1. Capsules Market, 2021 - 2033 (USD Million)
• 5.5. Powders
  • 5.5.1. Powders Market, 2021 - 2033 (USD Million)
• 5.6. Softgels
  • 5.6.1. Softgels Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Consumer Group Business Analysis

• 6.1. Segment Dashboard
• 6.2. Bone Density Supplements Market: Consumer Group Movement Analysis
• 6.3. Children
  • 6.3.1. Children Market, 2021 - 2033 (USD Million)
• 6.4. Adults
  • 6.4.1. Adults Market, 2021 - 2033 (USD Million)
• 6.5. Pregnant Women
  • 6.5.1. Pregnant Women Market, 2021 - 2033 (USD Million)
• 6.6. Geriatric Population
  • 6.6.1. Geriatric Population Market, 2021 - 2033 (USD Million)

Chapter 7. Sales Channel Business Analysis

• 7.1. Segment Dashboard
• 7.2. Bone Density Supplements Market: Sales Channel Movement Analysis
• 7.3. Brick And Mortar
  • 7.3.1. Brick And Mortar Market, 2021 - 2033 (USD Million)
    • 7.3.1.1. Direct Selling
      • 7.3.1.1.1. Direct Selling Market, 2021 - 2033 (USD Million)
    • 7.3.1.2. Chemists/Pharmacies
      • 7.3.1.2.1. Chemists/Pharmacies Market, 2021 - 2033 (USD Million)
    • 7.3.1.3. Health Food Shops
      • 7.3.1.3.1. Health Food Shops Market, 2021 - 2033 (USD Million)
    • 7.3.1.4. Hypermarkets
      • 7.3.1.4.1. Hypermarkets Market, 2021 - 2033 (USD Million)
    • 7.3.1.5. Supermarkets
      • 7.3.1.5.1. Supermarkets Market, 2021 - 2033 (USD Million)
• 7.4. E-Commerce
  • 7.4.1. E-Commerce Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Bone Density Supplements Market Share By Region, 2024 & 2033
• 8.2. North America
  • 8.2.1. North America Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Regulatory framework
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. U.S. Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Regulatory framework
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Canada Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.2.4. Mexico
    • 8.2.4.1. Key Country Dynamics
    • 8.2.4.2. Regulatory framework
    • 8.2.4.3. Competitive Scenario
    • 8.2.4.4. Mexico Bone Density Supplements Market, 2021 - 2033 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. UK Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Germany Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Regulatory framework
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. France Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Regulatory framework
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Italy Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Regulatory framework
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Spain Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Regulatory framework
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Denmark Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Regulatory framework
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Sweden Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Regulatory framework
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Norway Bone Density Supplements Market, 2021 - 2033 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Japan Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. China Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. India Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Australia Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.6. Thailand
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Thailand Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.4.7. South Korea
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. South Korea Bone Density Supplements Market, 2021 - 2033 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Brazil Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.5.3. Argentina
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Argentina Bone Density Supplements Market, 2021 - 2033 (USD Million)
• 8.6. MEA
  • 8.6.1. MEA Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. South Africa Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Saudi Arabia Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. UAE Bone Density Supplements Market, 2021 - 2033 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Kuwait Bone Density Supplements Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. New Chapter
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Nature Made
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Nature's Bounty
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Amway
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Life Extension
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Thorne
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Solgar Inc.
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Pure Encapsulations, LLC.
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Glanbia plc
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. NOW Foods
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives